The von Hippel–Lindau tumor suppressor protein
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 11 (1) , 27-34
- https://doi.org/10.1016/s0959-437x(00)00152-0
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor proteinThe EMBO Journal, 2000
- Comparative Sequence Analysis of the VHL Tumor Suppressor GeneGenomics, 2000
- Modification of Cullin-1 by Ubiquitin-like Protein Nedd8 Enhances the Activity of SCFskp2 toward p27kip1Biochemical and Biophysical Research Communications, 2000
- Ran-mediated Nuclear Export of the von Hippel-Lindau Tumor Suppressor Protein Occurs Independently of Its Assembly with Cullin-2Published by Elsevier ,2000
- Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau proteinJournal of Clinical Investigation, 1999
- Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC IsotypesBiochemical and Biophysical Research Communications, 1999
- Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activityOncogene, 1999
- Recombinant Adenovirus Expressing Von Hippel-Lindau-Mediated Cell Cycle Arrest Is Associated with the Induction of Cyclin-Dependent Kinase Inhibitor p27Kip1Biochemical and Biophysical Research Communications, 1998
- The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat familiesGenes & Development, 1998
- Regulation of gene expression for tyrosine hydroxylase in oxygen sensitive cells by hypoxiaKidney International, 1997